| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |